IRS
UTHR icon

Invictus RG (Singapore)’s United Therapeutics UTHR Stock Holding History

Invictus RG (Singapore)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-101
Closed -$13K – 725
2014
Q3 		$13K Sell
101
-1,606
-94% -$166K 0.02% 533
2014
Q2 		$151K Sell
1,707
-80
-4% -$7.69K 0.16% 252
2014
Q1 		$168K Buy
1,787
+1,284
+255% +$131K 0.2% 196
2013
Q4 		$57K Sell
503
-6,592
-93% -$594K 0.04% 431
2013
Q3 		$559K Buy
7,095
+3,699
+109% +$270K 0.48% 35
2013
Q2 		$224K Buy
+3,396
New +$219K 0.25% 153

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Invictus RG (Singapore)'s UTHR Position: Q4 2014 in Review

Invictus RG (Singapore) sold out of United Therapeutics (UTHR) in Q4 2014, closing a stake of 101 shares — an estimated $13K sold.

Invictus RG (Singapore) first reported a position in UTHR in Q2 2013 and held it in 6 quarters. The position peaked at $559K in Q3 2013. 334 funds tracked by Wall St. Rank hold UTHR as of Q4 2014.

  • Invictus RG (Singapore) reported no remaining United Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Invictus RG (Singapore) sold 101 United Therapeutics shares in Q4 2014, an estimated $13K.
  • Invictus RG (Singapore) first reported a position in United Therapeutics in Q2 2013 and held it in 6 quarters.
  • Invictus RG (Singapore)'s United Therapeutics position peaked at $559K in Q3 2013.
  • 334 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2014.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2014, filed 13 Feb 2015.